Neurocognitive Basis of Attention and Eye Movement Guidance in the Real World Scenes
調査の概要
状態
詳細な説明
The ability to conduct a visual search for an object in a naturalistic scene is a crucial component of everyday interactions with the environment. This process requires the recognition of different items, accessing stored semantic knowledge about those items and their relationships with other objects, and guiding vision based on that knowledge. Classical models of attention emphasize low-level visual salience maps for attentional guidance. However, behavioral studies increasingly support a role for object knowledge in guiding attention and eye movements. Despite strong behavioral evidence that conceptual information about objects and scenes is critical for real world guidance of attention, very little is known about the neural basis of the guidance of attention based on meaning.
Previous human imaging studies have identified several brain regions that represent object and scene/context knowledge as it relates to visual recognition. In particular, regions of the temporal lobes (inferior temporal regions (ITC), parahippocampal cortex (PHC), and the hippocampus) are critical for perceiving and understanding objects, but little is known about the role of these individual regions in how they interact to guide attention and eye movements in real-world scenes.
Electrical brain stimulation is routinely performed clinically in the surgical treatment of epilepsy patients, both intraoperatively and using implanted electrodes. It is used as standard of care both to map eloquent brain function prior to surgical treatment for epilepsy and to map the seizure network. The purpose of this study is to gain a better understanding of the information flow and neural dynamics of the brain, examining the impact of electrical brain stimulation on stimulus search time, accuracy, and eye movement trajectories.
研究の種類
段階
- 適用できない
連絡先と場所
研究場所
-
-
Pennsylvania
-
Pittsburgh、Pennsylvania、アメリカ、15213
- UPMC Presbyterian
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Have intracranial EEG electrodes implanted for stage II epilepsy planning.
- Have adequate cognitive and communication ability to give informed consent, understand instructions, and follow direction.
- Be able to understand the tasks and provide responses.
- IQ > 75 (done as part of standard-of-care neuropsychological testing as part of the surgical treatment for epilepsy)
- Speak English
Exclusion Criteria:
- Inability to understand or perform the tasks outlined in this protocol
- In excessive postoperative discomfort.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:基礎科学
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Electrical and Sham Electrical Brain Stimulation
Electrical brain stimulation and sham electrical brain stimulation will be administered to all participants.
|
Electrical Brain Stimulation (EBS) will be used to disrupt local neural activity in inferior temporal regions (ITC), parahippocampal cortex (PHC), the hippocampus, and control regions.
The effects of EBS will be examined on attention and eye movement behavior, and all participants will receive both EBS and sham electrical brain stimulation.
Sham electrical brain stimulation (SEBS) will be applied to inferior temporal regions (ITC), parahippocampal cortex (PHC), the hippocampus, and control regions.
The effects of SEBS will be examined on attention and eye movement behavior, and all participants will receive both SEBS and EBS.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Incidence of eye fixations during electrical brain stimulation (EBS) vs. sham electrical brain stimulation (SEBS).
時間枠:Eye fixation incidence will be assessed during the intervention, through study completion, up to 1 week on average.
|
Eye fixations will be assessed using an eye tracking device, which collects videos of eye movements.
Participants will be presented with an image of a scene, and asked to locate a target object.
The incidence of eye fixations occurring before participants locate the target object will be measured at preferred and control brain regions during EBS and SEBS.
|
Eye fixation incidence will be assessed during the intervention, through study completion, up to 1 week on average.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Search time for target object during EBS vs. SEBS.
時間枠:Search Time will be assessed during the intervention, through study completion, up to 1 week on average.
|
Visual search time will be assessed by asking participants to answer a simple question about a target object in an image of a scene as quickly and accurately as possible.
The question will presented to the participants, followed by the image of the scene.
The search time to locate the target object and respond to the question will be measured at preferred and control brain regions during EBS and SEBS.
|
Search Time will be assessed during the intervention, through study completion, up to 1 week on average.
|
|
Identification accuracy during EBS vs. SEBS.
時間枠:Identification accuracy will be assessed during the intervention, through study completion, up to 1 week on average.
|
Identification accuracy rate will be assessed based on the participants' correct responses for identifying a target object in an image of a scene (described in Outcomes 1 and 2).
The search time to locate the target object will be measured at preferred and control brain regions during EBS and SEBS.
|
Identification accuracy will be assessed during the intervention, through study completion, up to 1 week on average.
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Avniel S Ghuman, PhD、University of Pittsburgh
研究記録日
主要日程の研究
研究開始 (予想される)
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- STUDY19090010
- 1R21EY030297-01A1 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。